Breaking News Instant updates and real-time market news.

DBVT

DBV Technologies

$44.40

-1.36 (-2.97%)

08:36
08/25/17
08/25
08:36
08/25/17
08:36

DBV Technologies price target raised to $60 ahead of Phase 3 data at Leerink

Leerink analyst Dae Gon Ha previewed Phase 3 data due from DBV Technologies in the second half of the year, stating that he believes the company's novel patch to treat peanut allergy will likely show a 50% responder rate, adding that Key Opinion Leaders he's consulted would consider 66%-80% to be an "excellent" responder rate outcome. The analyst updated his EU model and raised his price target on DBV shares to $60 from $54, adding that he estimates "good" PEPITES data could imply a $9 move in the shares from current levels, while "excellent" data could mean a move of over $12.

  • 11

    Sep

DBVT DBV Technologies
$44.40

-1.36 (-2.97%)

08/17/17
JEFF
08/17/17
NO CHANGE
Target $51
JEFF
Buy
Expert sees positive DBV trial as highly likely, says Jefferies
A peanut allergy expert sees a high likelihood of Phase 3 success for DBV Technologies' Viaskin Peanut, Jefferies analyst Eun Yang tells investors in a research note. The data are expected in October or November. If the Phase 3 replicates the Phase 2 data, shares of DBV could rally 50% on the large commercial opportunity, Yang writes. She points out that downside risks are also "significant" if the study fails. The analyst remains positive on DBV with a Buy rating and $51 price target.
06/23/17
DBAB
06/23/17
INITIATION
Target $46
DBAB
Buy
DBV Technologies initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Andrew Peters started DBV Technologies with a Buy rating and $46 price target, as he believes the potential market opportunity for an FDA-approved treatment of childrens' peanut allergy would be "considerable" while approval of Viaskin Peanut would open the door to a host of other related allergies.
06/01/17
06/01/17
UPGRADE

DBV Technologies upgraded to Buy from Add at Gilbert Dupont
Gilbert Dupont analyst Damien Choplain upgraded DBV Technologies to Buy and raised his price target for the shares to EUR 120 from EUR 80. The stock in premarket trading is up 4% to $34.40.
03/22/17
PIPR
03/22/17
NO CHANGE
Target $38
PIPR
Overweight
Piper sees Aimmune as having regulatory advantage over DBV
After hosting investor meetings with management, Piper Jaffray analyst Charles Duncan keeps an Overweight rating on Aimmune (AIMT) with a $38 price target. While regulatory visibility will increase in the next 12 months, investors today should focus on response rates for the single highest tolerated dose, or how much peanut can an allergic person tolerate in a single exposure, Duncan tells investors in a research note. The analyst sees Aimmune's AR101 as having generated "uniquely impressive results" on the two key efficacy measures relative to DBV Technologies (DBVT), including both response rates and size of highest tolerated dose. He believes investors may be overlooking catalysts for Aimmune, including up-dosing progress from the PALISADE trial prior to Phase III results around year-end.

TODAY'S FREE FLY STORIES

COLL

Collegium Pharmaceutical

$25.70

-0.2 (-0.77%)

10:12
02/21/18
02/21
10:12
02/21/18
10:12
Hot Stocks
FDA says Collegium made false or misleading claims about Xtampza »

The FDA posted a letter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    Mar

VECO

Veeco

$18.35

-0.55 (-2.91%)

10:11
02/21/18
02/21
10:11
02/21/18
10:11
Conference/Events
Veeco management to meet with KeyBanc »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CLF

Cleveland-Cliffs

$7.62

-0.12 (-1.55%)

10:10
02/21/18
02/21
10:10
02/21/18
10:10
Options
Bearish option flow in Cleveland Cliffs »

Bearish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:10
02/21/18
02/21
10:10
02/21/18
10:10
General news
U.S. existing home sales preview: »

U.S. existing home sales…

MTCH

Match Group

$42.10

0.54 (1.30%)

, IAC

IAC

$149.83

0.74 (0.50%)

10:09
02/21/18
02/21
10:09
02/21/18
10:09
Hot Stocks
Match Group slips after analyst cuts rating on Tinder slowdown »

Shares of Match Group…

MTCH

Match Group

$42.10

0.54 (1.30%)

IAC

IAC

$149.83

0.74 (0.50%)

ANGI

Angi Homeservices

$14.60

0.58 (4.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

MOS

Mosaic

$27.78

1.0176 (3.80%)

10:05
02/21/18
02/21
10:05
02/21/18
10:05
Options
Mosaic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

10:05
02/21/18
02/21
10:05
02/21/18
10:05
General news
More from Harker: a trade war would not be good »

More from Harker: a trade…

ABBV

AbbVie

$120.00

2.02 (1.71%)

10:05
02/21/18
02/21
10:05
02/21/18
10:05
Recommendations
AbbVie analyst commentary  »

Piper says 'hard to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

10:04
02/21/18
02/21
10:04
02/21/18
10:04
General news
Existing Home Sales data reported »

January Existing Home…

RDWR

Radware

$21.09

-0.25 (-1.17%)

10:04
02/21/18
02/21
10:04
02/21/18
10:04
Conference/Events
Radware management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 29

    Mar

RDWR

Radware

$21.09

-0.25 (-1.17%)

10:01
02/21/18
02/21
10:01
02/21/18
10:01
Conference/Events
Radware management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 29

    Mar

QTWO

Q2 Holdings

$42.85

-1.8 (-4.03%)

10:00
02/21/18
02/21
10:00
02/21/18
10:00
Conference/Events
Q2 Holdings management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 15

    Mar

10:00
02/21/18
02/21
10:00
02/21/18
10:00
General news
U.S. Markit manufacturing PMI rose 0.4 points to 55.9 in the flash February »

U.S. Markit manufacturing…

LFUS

Littelfuse

$208.66

0.61 (0.29%)

09:59
02/21/18
02/21
09:59
02/21/18
09:59
Conference/Events
Littelfuse management to meet with Oppenheimer »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

NJDCY

Nidec

$37.80

-0.12 (-0.32%)

09:57
02/21/18
02/21
09:57
02/21/18
09:57
Conference/Events
Nidec management to meet with Oppenheimer »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

HDP

Hortonworks

$18.22

0.03 (0.16%)

09:55
02/21/18
02/21
09:55
02/21/18
09:55
Conference/Events
Hortonworks management to meet with Northland »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 26

    Feb

  • 11

    Mar

  • 13

    Mar

  • 14

    Mar

  • 11

    Apr

  • 30

    May

PVG

Pretium Resources

$6.56

-0.05 (-0.76%)

09:55
02/21/18
02/21
09:55
02/21/18
09:55
Options
Pretium Resources put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

  • 11

    Mar

AAP

Advance Auto Parts

$115.88

10.53 (10.00%)

, EXR

Extra Space Storage

$84.86

4.105 (5.08%)

09:55
02/21/18
02/21
09:55
02/21/18
09:55
Options
Early notable gainers among liquid option names on February 21st »

Notable gainers among…

AAP

Advance Auto Parts

$115.88

10.53 (10.00%)

EXR

Extra Space Storage

$84.86

4.105 (5.08%)

MOS

Mosaic

$27.48

0.72 (2.69%)

CF

CF Industries

$42.80

0.975 (2.33%)

VRSK

Verisk Analytics

$97.04

-1.75 (-1.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 30

    May

GVA

Granite Construction

$60.01

0.0066 (0.01%)

09:52
02/21/18
02/21
09:52
02/21/18
09:52
Conference/Events
Granite Construction management to meet with MKM Partners »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 23

    May

CPS

Cooper-Standard

$120.74

-0.8988 (-0.74%)

09:51
02/21/18
02/21
09:51
02/21/18
09:51
Conference/Events
Cooper-Standard management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 11

    Mar

LEXEB

Liberty Expedia Holdings

09:50
02/21/18
02/21
09:50
02/21/18
09:50
Hot Stocks
Breaking Hot Stocks news story on Liberty Expedia Holdings  »

Liberty Expedia Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANET

Arista Networks

$249.53

-0.125 (-0.05%)

09:50
02/21/18
02/21
09:50
02/21/18
09:50
Conference/Events
Arista Networks management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 26

    Feb

  • 06

    Mar

  • 13

    Mar

  • 14

    Mar

  • 29

    Mar

LEXEB

Liberty Expedia Holdings

09:45
02/21/18
02/21
09:45
02/21/18
09:45
Hot Stocks
Breaking Hot Stocks news story on Liberty Expedia Holdings  »

Liberty Expedia Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
02/21/18
02/21
09:45
02/21/18
09:45
General news
Existing Home Sales to be reported at 10:00 »

January Existing Home…

PM

Philip Morris

09:43
02/21/18
02/21
09:43
02/21/18
09:43
Earnings
Philip Morris sees Q1 EPS about 87c, including 3c of favorable currency 

Consensus is 90c.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.